PTAB statistics

PTAB Trial Statistics as of April 30, 2015

As of April 30, 2015, USPTO records show 3,173 AIA trial petitions filed since September 16, 2012 (2,833 IPR, 327 CBM, 5 PGR, 8 derivation). The Board had instituted trial on 1,461 petitions and denied 791 (64.9% instituted) and had issued 410 final written decisions. In fiscal year 2015 to that date, 1,092 petitions were filed.

Key Facts

As of
April 30, 2015
Fiscal year
FY2015
Petitions filed (cumulative)
3,173
Institution rate (cumulative)
64.9%
Petitions filed (FY2015 to date)
1,092
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of April 30, 2015
  2. Fiscal Year 2015 to Date
  3. Change Since April 9, 2015
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of April 30, 2015, which falls in fiscal year 2015 (October 1, 2014 to September 30, 2015). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2015 statistics page.

Cumulative Figures as of April 30, 2015

Events from September 16, 2012 to April 30, 2015, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed2,833532783,173
Institution decisions: instituted1,302015901,461
Institution decisions: denied7002863791
Institution rate (by petition)65.0%0.0%64.9%0.0%64.9%
Final written decisions3600500410
Terminations without a final written decisionCount
Settlements319
Adverse judgment0
Dismissed0
Other terminations25

Fiscal Year 2015 to Date

Events from October 1, 2014 to April 30, 2015:

MeasureIPRPGRCBMDERTotal
Petitions filed99239431,092
Institution decisions: instituted5630520615
Institution decisions: denied3472300379
Institution rate (by petition)61.9%0.0%63.4%—61.9%
Final written decisions2100330243
Terminations without a final written decisionCount
Settlements175
Adverse judgment0
Dismissed0
Other terminations17

Change Since April 9, 2015

Between the previous dated page (April 9, 2015) and April 30, 2015, 108 petitions were filed, 67 trials were instituted, 52 petitions were denied institution and 21 final written decisions issued. The cumulative institution rate moved from 65.4% to 64.9%.

Trial Types Covered

2,833 of the 3,173 petitions (89.3%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (327), post-grant review under chapter 32 (5) and derivation proceedings (8). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before April 30, 2015: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of April 30, 2015?

USPTO records show 3,173 petitions filed from September 16, 2012 to April 30, 2015: 2,833 IPR, 327 CBM, 5 PGR and 8 derivation.

What was the PTAB institution rate as of April 30, 2015?

Cumulatively, 64.9% by petition: 1,461 instituted and 791 denied. In FY2015 to that date the rate was 61.9%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.